Stop the Clot: Thrombosis Prevention Breakthroughs
Over the past few decades, currently available anticoagulants have proven to be effective at thrombosis prevention, however they are often underutilized, primarily due to safety concerns. Emerging evidence suggests that factor XI is a promising new target for the inhibition of pathological thrombosis and may become a future strategy for safer anticoagulation.
In this live social media event, interact with Drs Ruff and Gibson as they review the latest evidence and share their thoughts on the potential role of factor XI inhibition.
- - - -
MEET THE FACULTY
Christian T. Ruff, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Director of General Cardiology
Brigham and Women's Hospital
Senior Investigator, TIMI Study Group
Boston, Massachusetts
C. Michael Gibson, MS, MD
Professor of Medicine
Harvard Medical School
Interventional Cardiologist
Beth Israel Deaconess Medical Center
CEO, Nonprofit Baim Institute for Clinical Research
Boston, Massachusetts
- - - -
Please click here prior to the activity to view the full activity and disclosure information. https://img.medscapestatic.com/vim/li...
Supported by an independent educational grant from Anthos Therapeutics, Inc.